Symbol: |
TMEM181
|
Description: |
transmembrane protein 181 [Source:HGNC Symbol;Acc:20958]
|
Location: |
Chr6:158957468-159056460[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:124
Gene |
Compound |
Gen_sig |
Exp_pattern |
TMEM181 |
11H-Indeno[1,2-c]isoquinolinium, 9-hydroxy-2,3,8-trimethoxy-6-methyl-, chloride |
0.007 |
Down |
TMEM181 |
CI-941 |
0.048 |
Down |
TMEM181 |
5,5'-bis(2-methyl-1H-indol-3-yl)-3,3'-biisoxazole |
0.047 |
Down |
TMEM181 |
NSC 401101 |
0.02 |
Up |
TMEM181 |
NSC 408470 |
0.015 |
Up |
TMEM181 |
NSC 41274 |
0.016 |
Down |
TMEM181 |
FCDR |
0.024 |
Down |
TMEM181 |
Camptothecin ethylglycinate ester hydrochloride |
0.028 |
Down |
TMEM181 |
NSC 607281 |
0.045 |
Down |
TMEM181 |
NSC 611074 |
0.036 |
Up |
TMEM181 |
NSC 633912 |
0.027 |
Down |
TMEM181 |
Ethanedioic acid, mono(6-nitrobenzothiazol-2-yl)amide, mono[[2-(acetylhydrazino)-4-methylthiazol-5-yl]carbonyl] hydrazide |
0.047 |
Up |
TMEM181 |
23,27-Epoxy-3H-pyrido[2,1-c] [1,4]oxaazacyclohentriacontine-1,5,11,28,29-pentone-, 1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31, 32,33,34,34a-tetracosahydro- 27-hydroxy-10,21-dimethoxy-3-[2-[3-methoxy-4-[1-oxo- 3-(dimethylamino)propoxy]cyclohexy |
0.019 |
Up |
TMEM181 |
NSC 648624 |
0.017 |
Up |
TMEM181 |
1H-Pyrrolo[1,2-a]benzimidazole-5,8-dione, 6-(acetylamino)- 2,3-dihydro-3-[methoxy(acetyloxy)]-7-methyl- |
0.038 |
Up |
Expression pattern: Sensitivity / Resistance
Total:9 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:60
Total:4 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:2
Gene |
Gen_transcript |
miRNA |
miR_location |
TMEM181 |
ENST00000275254 |
hsa-mir-181d |
Chr19:13985724-13985746[+] |
TMEM181 |
ENST00000275254 |
hsa-mir-191-5p |
Chr3:49058105-49058127[-] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|